AAAAAA
Results:
1-17
|
Results: 17
Authors:
KATAJAMAKI J
HONKANEN A
PIEPPONEN TP
LINDEN IB
ZHARKOVSKY A
AHTEE L
Citation: J. Katajamaki et al., CONDITIONED PLACE PREFERENCE INDUCED BY A COMBINATION OF L-DOPA AND ACOMT INHIBITOR, ENTACAPONE, IN RATS, Pharmacology, biochemistry and behavior, 60(1), 1998, pp. 23-26
Authors:
NISSINEN E
KAIVOLA J
LINDEN IB
Citation: E. Nissinen et al., INHIBITION OF NEUTROPHIL ACTIVATION BY A NOVEL THIOL MODULATING COMPOUND OR-1384, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 2318-2318
Authors:
AHO P
KOPONEN A
HAASIO K
LINDEN IB
Citation: P. Aho et al., OR-1384, A NOVEL LOCALLY ACTING IMMUNOMODULATING AGENT, PROTECTS AGAINST EXPERIMENTAL COLITIS, Gastroenterology, 112(4), 1997, pp. 920-920
Authors:
MURTHY S
MURTHY NS
COPPOLA D
AHO P
LINDEN IB
Citation: S. Murthy et al., A NOVEL IMMUNOMODULATING AGENT (OR-1384) AMELIORATES INFLAMMATION ANDTISSUE-DAMAGE IN DEXTRAN SULFATE (DSS) MODEL OF MOUSE COLITIS, Gastroenterology, 112(4), 1997, pp. 1048-1048
Authors:
NISSINEN E
SERKKOLA E
PENTTILA KE
KAIVOLA J
AHO P
LINDEN IB
Citation: E. Nissinen et al., SUPPRESSION OF CYTOKINE PRODUCTION AND NEUTROPHIL ACTIVATION BY AN IMMUNOMODULATING AGENT OR-1384, Gastroenterology, 112(4), 1997, pp. 1051-1051
Authors:
NISSINEN E
KAHEINEN P
PENTTILA KE
KAIVOLA J
LINDEN IB
Citation: E. Nissinen et al., ENTACAPONE, A NOVEL CATECHOL-O-METHYLTRANSFERASE INHIBITOR FOR PARKINSONS-DISEASE, DOES NOT IMPAIR MITOCHONDRIAL ENERGY-PRODUCTION, European journal of pharmacology, 340(2-3), 1997, pp. 287-294
Authors:
HAIKALA H
KAHEINEN P
LEVIJOKI J
LINDEN IB
Citation: H. Haikala et al., THE ROLE OF CAMP-DEPENDENT AND CGMP-DEPENDENT PROTEIN-KINASES IN THE CARDIAC ACTIONS OF THE NEW CALCIUM SENSITIZER, LEVOSIMENDAN, Cardiovascular Research, 34(3), 1997, pp. 536-546
Authors:
AHO P
HAASIO K
LINDEN IB
Citation: P. Aho et al., HAPTEN-INDUCED MURINE COLITIS - A USEFUL MODEL FOR STUDYING TISSUE-LEVELS OF CYTOKINES, Gastroenterology, 110(4), 1996, pp. 852-852
Authors:
NISSINEN E
LINDEN IB
POHTO P
Citation: E. Nissinen et al., ANTIOXIDANT PROPERTIES OF NITECAPONE ARE POTENTIATED BY GLUTATHIONE, Biochemistry and molecular biology international, 35(2), 1995, pp. 387-395
Authors:
HAIKALA H
LINDEN IB
Citation: H. Haikala et Ib. Linden, MECHANISMS OF ACTION OF CALCIUM-SENSITIZING DRUGS, Journal of cardiovascular pharmacology, 26, 1995, pp. 10-19
Authors:
HAIKALA H
NISSINEN E
ETEMADZADEH E
LEVIJOKI J
LINDEN IB
Citation: H. Haikala et al., TROPONIN C-MEDIATED CALCIUM SENSITIZATION INDUCED BY LEVOSIMENDAN DOES NOT IMPAIR RELAXATION, Journal of cardiovascular pharmacology, 25(5), 1995, pp. 794-801
Authors:
HAIKALA H
KAIVOLA J
NISSINEN E
WALL P
LEVIJOKI J
LINDEN IB
Citation: H. Haikala et al., CARDIAC TROPONIN-C AS A TARGET PROTEIN FOR A NOVEL CALCIUM SENSITIZING DRUG, LEVOSIMENDAN, Journal of Molecular and Cellular Cardiology, 27(9), 1995, pp. 1859-1866
Authors:
HAIKALA H
LEVIJOKI J
LINDEN IB
Citation: H. Haikala et al., TROPONIN C-MEDIATED CALCIUM SENSITIZATION BY LEVOSIMENDAN ACCELERATESTHE PROPORTIONAL DEVELOPMENT OF ISOMETRIC TENSION, Journal of Molecular and Cellular Cardiology, 27(10), 1995, pp. 2155-2165
Authors:
LAULAJAINEN T
HEINONEN T
AHO P
LINDEN IB
Citation: T. Laulajainen et al., EFFECT OF OR-1364 ON CYTOKINE RELEASE IN EPITHELIAL-MONONUCLEAR CELL COCULTURES, Gastroenterology, 108(4), 1995, pp. 859-859
Authors:
AHO P
KOPONEN A
HAASIO K
LINDEN IB
Citation: P. Aho et al., OR-1364 INHIBITS THE DEVELOPMENT OF IMMUNE-COMPLEX COLITIS IN RABBITS, Gastroenterology, 106(4), 1994, pp. 10000643-10000643
Authors:
NISSINEN E
LAULAJAINEN T
HOLOPAINEN A
KAIVOLA J
AHO P
LINDEN IB
Citation: E. Nissinen et al., SUPPRESSION OF NEUTROPHIL AND T-LYMPHOCYTE ACTIVATION BY AN ANTICOLITIS AGENT OR-1364, Gastroenterology, 106(4), 1994, pp. 10000745-10000745
Authors:
AHO P
NISSINEN E
PENTTILA K
HAASIO K
LINDEN IB
Citation: P. Aho et al., THE SULFHYDRYL MODULATING COMPOUND OR-1364 PROTECTS AGAINST FREE-RADICAL INDUCED COLITIS IN RATS, Gastroenterology, 104(4), 1993, pp. 659-659
Risultati:
1-17
|